News


Publications
12 March 2018

Joint success of Selvita S.A. and Chabasiewicz, Kowalska i Partnerzy

 The newly issued shares of the Krakow-based Selvita were promptly sold. Investors declared to buy the whole offering at the maximum price. Some even wanted more. This will be a solid capital inflow for the company. Selvita laboratories have already developed a potential medicine currently administered to patients in the US.

The firm was Selvita’s legal adviser.

https://www.money.pl/gospodarka/wiadomosci/artykul/selvita-nowa-emisja-spolka-biotechnologiczna,123,0,2398587.html